series-c-plus
Stage
2
Investors
About
Endotronix develops the FDA-approved Cordella Pulmonary Artery Sensor System, a remote monitoring medical device designed to measure pulmonary artery pressure and vital signs to assist clinicians in proactively managing NYHA Class III heart failure patients and reducing hospitalizations.
Explore Endotronix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.